From Biological Understanding to Clinical Exploitation /
First Statement of Responsibility
edited by Arnold von Eckardstein, Dimitris Kardassis.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
XIII, 694 p. 40 illus., 37 illus. in color.
Other Physical Details
online resource.
SERIES
Series Title
Handbook of Experimental Pharmacology,
Volume Designation
224.
ISSN of Series
0171-2004 ;
CONTENTS NOTE
Text of Note
Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.
0
SUMMARY OR ABSTRACT
Text of Note
In this Handbook of Experimental Pharmacology on "High Density Lipoproteins - from biological understanding to clinical exploitation" contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.